Comparative evaluation of clinical efficacy of Origanum oil, Magnolia oil, Cranberry oil and Tea tree oil oral in-situ gels as local drug delivery in the treatment of Stage -I and Stage-II Periodontitis

Periodontal disease is a significant global public health concern affecting individuals across all demographics. It encompasses inflammatory conditions like gingivitis and periodontitis, with the latter leading to irreversible damage such as alveolar bone resorption and periodontal ligament detachment. The disease is primarily initiated by gram-negative bacterial colonization, which stimulates a destructive host immune response through the release of pro-inflammatory mediators like IL-1 and PGE2.

Traditional treatment through scaling and root planing (SRP) helps reduce microbial load but is limited in accessing deeper periodontal pockets. Although systemic antibiotics are effective, they pose risks such as antibiotic resistance and secondary infections. To overcome these limitations, localized drug delivery systems have gained attention, offering targeted treatment with fewer systemic side effects. However, many synthetic agents still cause undesirable effects like gastrointestinal distress and tooth staining.

As a result, attention has shifted to phytotherapy, which explores natural plant-based agents with antimicrobial and anti-inflammatory properties. Several herbal compounds have demonstrated potential in periodontal therapy. Carvacrol, derived from Origanum vulgare, exhibits antibacterial, anti-inflammatory, and antioxidant properties. Magnolol, a bioactive compound from Magnolia officinalis, shows diverse pharmacological benefits including antibacterial and anti-inflammatory actions. Cranberry extracts, particularly rich in proanthocyanidins, hinder bacterial adhesion and proteolytic activity of key periodontopathogens. Tea tree oil, containing active constituents like 1,8-cineole and terpinen-4-ol, demonstrates antimicrobial efficacy comparable to chlorhexidine with a different mechanism of action and better biocompatibility.

Given these promising properties, the present study proposes to evaluate and compare the clinical efficacy of in situ oral gels formulated from Carvacrol (Origanum vulgare oil), Magnolol (Magnolia officinalis oil), Vaccinium macrocarpon (cranberry) oil, and Tea Tree Oil as adjuncts to SRP in managing Stage-1 and Stage-2 periodontitis. These natural alternatives may offer effective periodontal therapy with fewer adverse effects.